Latest Breaking News On - Amed therapeutics - Page 1 : comparemela.com

CytoMed Therapeutics Limited (NASDAQ:GDTC) Sees Significant Increase in Short Interest

CytoMed Therapeutics Limited (NASDAQ:GDTC – Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 39,400 shares, a growth of 11.6% from the March 31st total of 35,300 shares. Based on an average trading volume of 25,100 shares, the short-interest ratio […]

Cannabis Stocks: Here's How to Maximize Your Gains Amid Sector's Strong Resurgence

Cannabis Stocks: Here's How to Maximize Your Gains Amid Sector's Strong Resurgence

AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery, and Ocular Itching Associated with Allergic Conjunctivitis

SHANGHAI, Feb. 19, 2024 /PRNewswire/ AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing transformative

AffaMed's Dextenza NDA Accepted In Singapore For Treating Ocular Inflammation And Pain

(RTTNews) - AffaMed Therapeutics said that the Singapore Health Sciences Authority has accepted its New Drug Application or NDA for Dextenza (0.4 .